IBD/IBS/Coeliac Flashcards
Intestinal Features of Crohn’s disease (CD)
Diarrhoea usually non-bloody
Weight loss more prominent
Upper gastrointestinal symptoms, mouth ulcers, perianal disease
Abdominal mass palpable in the right iliac fossa
Intestinal Features of Ulcerative colitis (UC)
Bloody diarrhoea more common
Abdominal pain in the left lower quadrant
Tenesmus
Extra- Intestinal Features of Crohn’s disease (CD)
Gallstones are more common secondary to reduced bile acid reabsorption
Oxalate renal stones*
Extra - Intestinal Features of Ulcerative colitis (UC)
Primary sclerosing cholangitis more common
Complications of Crohn’s disease (CD)
Obstruction, fistula, colorectal cancer
small bowel cancer
osteoporosis
Risk of colorectal cancer high in UC than CD
true
Pathology of Crohn’s?
Lesions may be seen anywhere from the mouth to anus
Skip lesions may be present
Pathology of UC?
Inflammation always starts at rectum and never spreads beyond ileocaecal valve
Continuous disease
Histology of Crohn’s?
Inflammation in all layers from mucosa to serosa
increased goblet cells
granulomas
Histology of UC?
No inflammation beyond submucosa (unless fulminant disease) - inflammatory cell infiltrate in lamina propria
neutrophils migrate through the walls of glands to form crypt abscesses
depletion of goblet cells and mucin from gland epithelium
granulomas are infrequent
Endoscopy of Crohn’s
Deep ulcers, skip lesions - ‘cobble-stone’ appearance
Endoscopy of UC
Widespread ulceration with preservation of adjacent mucosa which has the appearance of polyps (‘pseudopolyps’)
Which enemas are used when?
Crohn’s - Small bowel enema
UC - Barium enema
Radiology finding in Crohn’s
high sensitivity and specificity for examination of the terminal ileum strictures: 'Kantor's string sign' proximal bowel dilation 'rose thorn' ulcers fistulae
Radiology in UC
loss of haustrations
superficial ulceration, ‘pseudopolyps’
long standing disease: colon is narrow and short -‘drainpipe colon’
Crohn’s disease is a form of inflammatory bowel disease. It commonly affects the
terminal ileum and colon but may be seen anywhere from the mouth to anus.
Crohn’s are prone to strictures, fistulas and adhesions because?
inflammation occurs in all layers, down to the serosa.
Crohn’s disease typically presents in
late adolescence or early adulthood
Crohn’s disease bloods?
raised inflammatory markers
increased faecal calprotectin
anaemia
low vitamin B12 and vitamin D
most common extra-intestinal feature in both CD and UC
Arthritis: pauciarticular, asymmetric
Episcleritis is more common in CD
True
Features Common to both Crohn’s disease (CD) and Ulcerative colitis (UC) AND RELATED to disease activity
Arthritis: pauciarticular, asymmetric
Erythema nodosum
Episcleritis
Osteoporosis
Features Common to both Crohn’s disease (CD) and Ulcerative colitis (UC) AND UNRELATED to disease activity
Arthritis: polyarticular, symmetric Uveitis Pyoderma gangrenosum Clubbing Primary sclerosing cholangitis
Primary sclerosing cholangitis is much more common and Uveitis is more common in UC
true
Crohn’s disease which bloods correlates well with disease activity
C-reactive protein
CD investigation of choice?
colonoscopy
Crohn’s disease patients should be strongly advised to stop smoking
true
Crohn’s disease: management - Inducing remission first line?
glucocorticoids (oral, topical or intravenous) are generally used to induce remission.
Budesonide is an alternative in a subgroup of patients
enteral feeding with an elemental diet may be used in addition to or instead of other measures to induce remission, particularly if there is concern regarding the side-effects of steroids (for example in young children)
Crohn’s disease: management - Inducing remission second line?
5-ASA drugs (e.g. mesalazine) are used second-line to glucocorticoids but are not as effective
Methotrexate is an alternative to azathioprine
Crohn’s disease: management add on medication
azathioprine or mercaptopurine* may be used as an add-on medication to induce remission but is not used as monotherapy
Crohn’s disease: management
refractory disease and fistulating Crohn’s
infliximab is useful in refractory disease and fistulating Crohn’s. Patients typically continue on azathioprine or methotrexate
Crohn’s disease: management
isolated peri-anal disease
metronidazole
Crohn’s disease: management - Maintaining remission
as above, stopping smoking is a priority (remember: smoking makes Crohn’s worse, but may help ulcerative colitis)
azathioprine or mercaptopurine is used first-line to maintain remission
methotrexate is used second-line
5-ASA drugs (e.g. mesalazine) should be considered if a patient has had previous surgery